Megan Bozek and Sami Jo Small join Laura Diakun to discuss the amazing chemistry between Abbey Murphy to Taylor Heise in the United States' win, and point out the positives from Canada in the loss.

Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

A new generation of shoppers isn’t afraid to be upfront about buying dupes. Lululemon, however, isn’t having it.

US stock futures kick off November in the green as investors await earnings from Palantir (PLTR), AMD (AMD), and Qualcomm ...

In what is being called one of the largest corporate takeovers in years, Kimberly-Clark is buying Tylenol parent company, ...

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to autism.

Kenvue stock share price today shows a major surge after Kimberly-Clark announced plans to buy Kenvue for over $40 billion.

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer product conglomerate.